We ship !

We are not shipping goods to USA
except BioBeam 940

Syrolight The Company

syrolightthecompaney

SyroLight Ltd develops and markets medical devices utilizing proprietary low level narrow band (LLNB) light technology for non-invasive, drug-free treatment of various disorders such as hay fever, skin lesions, rheumatic pain and oral problems. This technology, marketed under the “BioLight” brand name, is protected by patent granted in the US, Japan and Israel with several additional patents pending for specific applications. Led by a team of scientists and physicians, SyroLight offers technological and scientific expertise coupled with sound manufacturing capabilities.

 

BioNase the Company’s first product for the mass market, is a breakthrough system that uses phototherapy to offer drug-free, painless relief from nasal congestion, runny nose, sneezing, itching, and teary eyes that characterize Allergic Rhinitis (hay fever). BioNase has proven highly effective in the treatment of Allergic Rhinitis. In a double blind study, over 72% of the patients treated with BioNase reported overall significant improvements in their condition, as compared to only 3% in the study’s control group.

Syro’s newest development, BioStick has proven highly effective in treating oral problems such as Aphtous ulcers, inflammation caused by Gingivitis, bad breath and cold sores.

The Company’s BioBeam line of products is supported by many years of extensive research and clinical tests conducted at major hospitals and academic institutions in Israel and Europe, in which more that a thousand patients were treated using the BioBeam products. Some of these studies were published in internationally acclaimed scientific journals such as The Journal of the American Geriatrics Society and Orthopedics.

BioBeam 660 is a proven phototherapeutic system for the treatment of severe wounds, such as diabetic ulcers, bed-sores (decubiti), venous ulcers, post-operative wounds and various types of gangrene. The BioBeam 660 is a hand-held unit intended for personal home use. As its name indicates, the device uses non-coherent narrow bandwidth light at 630nm.

Another product, BioBeam 940 is used to alleviate chronic pain associated with rheumatic and rheumatoid arthritis pains in small joints, and for the treatment of soft tissue disorders, such as tendonitis. The BioBeam 940 can either be used as an alternative or in conjunction with pharmaceuticals and physiotherapy.

Double blind tests have documented that treatment with BioBeam significantly lessens pain associated with chronic tendonitis and facet joint arthritis. Patients with degenerative knee diseases and chondromalacia patella also showed a significant improvement in pain tolerance, power and ability to walk and negotiate stairs.

The Company’s PRO162 line is a more powerful version of the BioBeam 660 featuring 500mW light power and is intended for use in clinics. Its intense light source makes it an effective tool for treating repetitive stress pains such as pains in the hands and wrists due to use of computer keyboards, tendonitis (inflammation of the tendon), back pains, joint inflammation, and restricted movement problems.

All BioBeam products are safe and easy to use thereby allowing self-treatment.

Syro’s line of products represents a major breakthrough in the non-pharmacological treatment of the above-mentioned widespread and distressing clinical conditions. The impressive efficacy of Syro’s phototherapy products and their lack of side effects or adverse reactions, indicate their potential for widespread application.

SyroLight Ltd is fully committed to the continued development of new products based on low level narrow band (LLNB) for the treatment of clinical disorders that are highly prevalent and widespread. The company is thus well-positioned for dramatically increasing its sales and reaching profitability in the near future.

Syrolight The Company

syrolightthecompaney

SyroLight Ltd develops and markets medical devices utilizing proprietary low level narrow band (LLNB) light technology for non-invasive, drug-free treatment of various disorders such as hay fever, skin lesions, rheumatic pain and oral problems. This technology, marketed under the “BioLight” brand name, is protected by patent granted in the US, Japan and Israel with several additional patents pending for specific applications. Led by a team of scientists and physicians, SyroLight offers technological and scientific expertise coupled with sound manufacturing capabilities.

 

BioNase the Company’s first product for the mass market, is a breakthrough system that uses phototherapy to offer drug-free, painless relief from nasal congestion, runny nose, sneezing, itching, and teary eyes that characterize Allergic Rhinitis (hay fever). BioNase has proven highly effective in the treatment of Allergic Rhinitis. In a double blind study, over 72% of the patients treated with BioNase reported overall significant improvements in their condition, as compared to only 3% in the study’s control group.

Syro’s newest development, BioStick has proven highly effective in treating oral problems such as Aphtous ulcers, inflammation caused by Gingivitis, bad breath and cold sores.

The Company’s BioBeam line of products is supported by many years of extensive research and clinical tests conducted at major hospitals and academic institutions in Israel and Europe, in which more that a thousand patients were treated using the BioBeam products. Some of these studies were published in internationally acclaimed scientific journals such as The Journal of the American Geriatrics Society and Orthopedics.

BioBeam 660 is a proven phototherapeutic system for the treatment of severe wounds, such as diabetic ulcers, bed-sores (decubiti), venous ulcers, post-operative wounds and various types of gangrene. The BioBeam 660 is a hand-held unit intended for personal home use. As its name indicates, the device uses non-coherent narrow bandwidth light at 630nm.

Another product, BioBeam 940 is used to alleviate chronic pain associated with rheumatic and rheumatoid arthritis pains in small joints, and for the treatment of soft tissue disorders, such as tendonitis. The BioBeam 940 can either be used as an alternative or in conjunction with pharmaceuticals and physiotherapy.

Double blind tests have documented that treatment with BioBeam significantly lessens pain associated with chronic tendonitis and facet joint arthritis. Patients with degenerative knee diseases and chondromalacia patella also showed a significant improvement in pain tolerance, power and ability to walk and negotiate stairs.

The Company’s PRO162 line is a more powerful version of the BioBeam 660 featuring 500mW light power and is intended for use in clinics. Its intense light source makes it an effective tool for treating repetitive stress pains such as pains in the hands and wrists due to use of computer keyboards, tendonitis (inflammation of the tendon), back pains, joint inflammation, and restricted movement problems.

All BioBeam products are safe and easy to use thereby allowing self-treatment.

Syro’s line of products represents a major breakthrough in the non-pharmacological treatment of the above-mentioned widespread and distressing clinical conditions. The impressive efficacy of Syro’s phototherapy products and their lack of side effects or adverse reactions, indicate their potential for widespread application.

SyroLight Ltd is fully committed to the continued development of new products based on low level narrow band (LLNB) for the treatment of clinical disorders that are highly prevalent and widespread. The company is thus well-positioned for dramatically increasing its sales and reaching profitability in the near future.